Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Nike (NKE) PT Raised to $64 at Canaccord Genuity Ahead of FQ2 Earnings Announcement on Dec. 21
-
Darden Restaurants (DRI) PT Maintained at $97 at Canaccord Genuity on 2Q Earnings Preview; 'Upside Possible Supported by Improved Industry Backdrop'
-
Aura Minerals Inc. and Rio Novo Gold Inc. Announce Merger Transaction
-
Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock
-
Cryptocurrency Mining Company HashChain Technology is Publicly-Listed on the TSX Venture Exchange under the symbol KASH
-
Millrock Closes Non-Brokered Private Placement
-
Pre-Open Movers 12/15: (DDR) (ALNY) (HES) Higher; (TROV) (VSTM) (CSX) Lower (more...)
-
Canaccord Genuity Upgrades Foot Locker (FL) to Buy
-
Canaccord Genuity Starts Intra-Cellular Therapies (ITCI) at Buy, 'Lumateperone on track as ITCI steadily builds a pipeline'
-
MAXIMUS (MMS): Canaccord Raises PT After Two Days Of Investor Meetings
-
Trupanion (TRUP): Canaccord Raises PT $5 After Management Meetings
-
Aspen Technology (AZPN): Outlook Steady But Inflection Is Not Here Yet - Canaccord
-
Vernalis PLC: AGM Statement
-
Dalradian intersects 0.74 metres at 82.47 g/t gold in Step-out Drilling at Curraghinalt
-
Helios and Matheson (HMNY) Prices $60M Common Stock and Warrant Offering
-
Helios and Matheson Analytics Announces Pricing of $60 Million Public Offering
-
Hexcel Corp. (HXL): Investor Day Commentary Supports FCF Upside, PT To $64 - Cannacord
-
AECOM Technology (ACM): Guidance Bump Drives PT To $40 - Cannacord
-
Blueprint Medicines (BPMC) Prices 3.7M Share Offering at $81/Sh
-
Vernalis + Daiichi Sankyo Enter Collaboration
-
Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
-
Helios and Matheson (HMNY) Commences 'Best Efforts' Offering of Common Stock and Warrants
-
Helios and Matheson Analytics Announces Proposed Public Offering of Common Stock and Warrants
-
Canaccord Genuity Starts SailPoint Technologies Holdings (SAIL) at Hold
-
Pershing Gold Announces Bought Deal of US$6.8 Million and Private Placement of US$6.8 Million
-
Pershing Gold (PGLC) Announces $6.8M Common Stock and Warrant Bought Deal
-
Pershing Gold Announces Bought Deal of $6.8 Million
-
Blueprint Medicines (BPMC) to Offer $275M in Common Stock
-
Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
-
AltaGas Ltd. Announces Monthly Dividend
-
Entellus Medical (ENTL) PT Raised to $24 at Canaccord Genuity Following Acquisition by Stryker (SYK)
-
bluebird bio (BLUE) PT Raised to $228 at Canaccord Genuity Following ASH Conference
-
Cubic (CUB) PT Raised to $66 at Canaccord Genuity Following Management Meeting
-
Brookfield Property Partners L.P. (BPY) Likely To Increase Bid Significantly For GGP Inc. (GGP) - Canaccord
-
Lending Club (LC) PT Lowered to $5 at Canaccord Genuity Following Investor Day
-
Edwards Lifesciences (EW) PT Raised to $140 at Canaccord Genuity, 'We Would Be Aggressive Buyers'
-
Sage Therapeutics (SAGE) PT Raised to $191 at Canaccord Genuity
-
Broadcom (AVGO): Strong Q4/17 Results, PT To $317 - Canaccord
-
Canaccord Genuity Upgrades Lululemon Athletica Inc. (LULU) to Hold, 'Innovating through the denim cycle'
-
Deckers Brands Mails Letter to Stockholders Highlighting Significant Support from Independent Experts
-
AeroVironment (AVAV) PT Raised to $50 at Canaccord Genuity, 'Full Year 2018 Guidance Looks Conservative'
-
Vernalis and Servier Achieve Research Milestone
-
Seaport Global Securities Expands Healthcare Team
-
Tyme Provides Update on At-The-Market Financing Activity
-
Canaccord Genuity Starts bluebird bio (BLUE) at Buy Noting Long-term bb2121 Potential Is Interesting
-
Canaccord Genuity Starts Bandwidth Inc. (BAND) at Buy
-
Zynerba Pharmaceuticals (ZYNE) PT Raised to $18 at Canaccord Genuity
-
Pre-Open Movers 12/01: (UQM) (FMI) (NTNX) Higher; (GCO) (ULTA) (LLNW) Lower (more...)
-
Ambarella (AMBA) PT Raised to $67 at Canaccord Genuity, Bull Case Target Remains at $100
-
Canaccord Genuity Starts Plug Power (PLUG) at Buy


